Sheila Gujrathi - 31 Dec 2022 Form 5 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
13 Feb 2023, 18:10:55 UTC
Previous filing
16 Jun 2022
Next filing
31 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Gift $0 -32,987 -100% $0.000000* 0 21 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.